Bringing the fundamentals into focus…
Back to Ironwood Pharmaceuticals, Inc.
How Ironwood Pharmaceuticals, Inc. stacks up
IRWD · against 1,336 other Healthcare companies
Valuation
96/ 100
Near the top of its peers.
Ranked #44 of 1,337 · scores higher than 96% of peers
Bars: peers in each 10-point band of the valuation score141 peers with a valuation score of 90–100, including IRWD · Click a bar to see the companies
Why valuation scores 96?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield, free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
- more operating profit (EBITDA) for the company's total value: stronger than 97% of peers. EBITDA yield: 33.7% vs peer median 4.0%
- higher earnings for the price paid: stronger than 99% of peers. Earnings yield: 22.5% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 99% of peers. Free cash flow yield: 32.1% vs peer median 0.0%
Metric by metric
Position: dot = IRWD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IRWD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 22.0% | 1.5% | 99% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 26.6% | 4.2% | 97% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 32.1% | -1.0% | 99% | 20% | |
| Book yieldHigher is better · 1,306 reported | -28.0% | 37.9% | 2% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around IRWD| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 44 | 188M CHF (≈$216M) | 96 | 74 | |
| 44 | 433M USD | 96 | 81 | |
| 44 | 289M USD | 96 | 57 | |
| 44 | 810M USD | 96 | 69 | |
| 44 | 578M USD | 96 | 73 | |
| 44 | 2.1B USD | 96 | 96 | |
| 44 | 1.2B USD | 96 | 75 | |
| 44 | 1.3B BRL (≈$238M) | 96 | 77 | |
| 44 | 10.4B USD | 96 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score